Could screening help a family sooner? Could closer follow-up improve someone’s treatment? These are questions we carry from our everyday work into conversations with fellow professionals.
Rajat Kumar Agarwal, President of Sankalp India Foundation, received the “Guardian of Humanity” recognition at the Navdashakotsav Global Summit 2026, organised by Brahma Kumaris at Abu Road, Rajasthan.
“Your visionary leadership towards advancing stem cell transplants, transforming lives and bringing hope to thousands of families is worthy of acclaim and recognition,” they said.
Recognition from fellow professionals encourages us to keep improving the care families count on.
A year after Happiness Amanda’s bone marrow transplant, her family sent us a celebration from Kenya, Amanda sharing a cake with her Bone marrow donor.
On the cake, her mother chose Aksha, meaning blessing, and Cushy referring to happiness. Beside it stood her two girls: one who had received a second chance at life, and one who had helped make it possible.
For a parent whose child needs regular blood transfusions, learning that a transplant could offer a cure brings hope. But another question soon follows: can we reach that care, and can we afford it? A collaborative study involving Sankalp, Cure2Children Foundation and partner centres explores how more families could have that opportunity.
“I know more hospitals than tourist places.”
Kaustav Ghosh’s words stay with you. Growing up with thalassemia in Jamshedpur, he faced more than hospital visits. Some people warned others not to sit beside him, wrongly believing the condition could spread through touch.
Treatment interrupted college. His father’s retirement savings went towards hospital care. Finding work was difficult, and the next transfusion was always something to plan around.
